Richard Kasprowicz


Richard is a Scientific Investigator in Imaging at GSK Stevenage UK, where he leads advanced analytic capabilities and development of high-content imaging screens for small molecules. He obtained his PhD in Immunology and Cell Biology at the University of York in 2014, going on to work as a Senior Applications Scientist at Phasefocus to explore the use of phase measurements derived from a novel label-free imaging technology.

In 2018, he joined GSK and has developed numerous high-content assays across the drug discovery portfolio, focusing particularly on imaging assays that are now embedded within routine early safety screening. He has initiated application of AI/ML techniques across target identification and hit confirmation imaging programs and pursues further advancement of internal resources in the field with AI specialists. As a founding member of the GSK Imaging Hub, Richard continues to provide training in image analysis and assay design to scientists across the organization and champions inter-sector mobility via multiple academic collaborations.